Roche condemns 'act of counterfeiting' as authorities in Pakistan crack down on unapproved Avastin use

After several diabetic patients received a sham version of Roche's Avastin and lost their sight, the Drug Regulatory Authority of Pakistan (DRAP) is halting the sale or distribution of the drug until it can verify quality, the agency said in a release Sunday.